Dehiscence of abdominal surgical wounds is a medical emergency and requires immediate action to reduce further complications. Knowing who is at risk and the…
The ECRI Institute recently launched its Coronavirus Outbreak Preparedness Center for healthcare providers and hospitals to learn how to protect themselves and their patients.…
Hospital-acquired pneumonia (HAP) is a serious complication of an acute care admission, particularly for patients noted to be at risk. HAP can be reduced…
The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for children suffering from peanut allergy. (more…)
On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the…
A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C, hydrocortisone, and…
On the heels of today’s earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York Times (NYT) just released an article…
In late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved vaccine to prevent Ebola…
Everyone knows the bad news: Bacterial resistance to antibiotics is common. The good news is that healthcare providers, public health organizations like the Centers…
The ECRI Institute recently launched its Coronavirus Outbreak Preparedness Center for healthcare providers and hospitals to learn how to protect themselves and…
The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for children suffering from peanut…
Everyone knows the bad news: Bacterial resistance to antibiotics is common. The good news is that healthcare providers, public health organizations like…